Science

New optogenetic tool inhibits activity in neurons and heart muscle cells

Read full article at source ↗

Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 21/10/2026, 23:25:25 UTC.

Briefings

Researchers from Ruhr University Bochum and international collaborators developed optogenetic tools to selectively inhibit cellular activity using light. This advancement aims to investigate diseases where excitation and inhibition balance is disrupted, specifically cardiac arrhythmias. The study represents a significant step in optogenetics but remains in early development phases.

Key points

• Researchers from Ruhr University Bochum partnered with colleagues in Göttingen, Berlin, Paris, and Essen to develop new optogenetic tools.
• These tools enable selective inhibition of cellular activity via light, targeting diseases with disrupted excitation-inhibition balance like cardiac arrhythmias.

Context

The study involves international collaboration across multiple European institutions to advance optogenetic technology for medical research.

Limitations

Evidence is limited to the initial development phase; specific experimental results, patient data, or clinical outcomes are not provided.

Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 21/10/2026, 23:27:24 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.

View archived briefing on IPFS
bafybeieyqptgsepttf7nm64tyuxrydorrtxgxw6uhhkgezf6asg556owem